1073-2322
Monthly
No
SHOCK
1994
188
UNITED STATES
http://www.editorialmanager.com/shock/
约1.0个月审稿时间
3区中科院分区
50%平均录用比例
2.9影响因子
危重病医学小学科
54/312JIF RANK
8479总被引频次
休克包括研究新的治疗方法,如免疫调节、基因治疗、营养和其他。目前还没有一本包含病因、细胞和分子机制以及以综合和连贯的方式治疗休克的治疗方法的杂志,但仍保持对休克病理学的明确关注。该杂志将满足研究人员目前和未来的需求,他们参与了对休克、创伤、败血症、内毒素血症、缺血/再灌注、炎症和其他相关病理生理状态的复杂基础和临床研究。
http://www.editorialmanager.com/shock/
Shock includes studies of novel therapeutic approaches, such as immunomodulation, gene therapy, nutrition, and others. There is no single journal, which encompasses the etiology, cellular and molecular mechanisms, and therapeutic approaches to the treatment of shock in a comprehensive and coherent manner, while still maintaining a clear focus on the pathobiology of shock. The journal is poised to meet the present and future needs of investigators involved in sophisticated basic and clinical studies of shock, trauma, sepsis, endotoxemia, ischemia/reperfusion, inflammation, and other related pathophysiologic states.
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 2区 | SURGERY 外科 CRITICAL CARE MEDICINE 危重病医学 HEMATOLOGY 血液学 PERIPHERAL VASCULAR DISEASE 外周血管病 | 2区 3区 3区 3区 | 否 | 否 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q2 | SURGERY | Q2 | 3.533 |
PERIPHERAL VASCULAR DISEASE | Q2 | ||
CRITICAL CARE MEDICINE | Q3 | ||
HEMATOLOGY | Q3 |
CiteScore | SJR | SNIP | 学科类别 | 分区 | 排名 | 百分位 |
6.10 | 0.851 | 0.947 | 大类:Medicine 小类:Emergency Medicine | Q1 | 6 / 90 |
93% |
大类:Medicine 小类:Critical Care and Intensive Care Medicine | Q1 | 15 / 89 |
83% |
影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
3.533 | 106 | 6.81% | 82.35% | 未开放 | 约1.0个月 |